Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the ...

Barclays analyst Andrew Mok CFA maintained a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of $512.00. The ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

Shares of Elevance Health Inc. ELV rallied 1.11% to $435.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

Equities researchers at Wolfe Research issued their FY2029 earnings per share (EPS) estimates for Elevance Health in a note issued to investors on Monday, March 31st. Wolfe Research analyst J. Lake ...

Importantly, Elevance Health, Inc. (NYSE:ELV) does carry debt. But the more important question is: how much risk is that debt creating? Debt assists a business until the business has trouble ...

3 Reasons We’re Fans of Elevance Health (ELV) Elevance Health trades at $423.06 per share and has stayed right on track with the overall market, losing 14% over the last six months while the S&P ...

With a market cap of $102.5 billion, Elevance Health ... services across its four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It provides health plans ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...